Sindhu Ram K, Ehdaie Ashkan, Vaziri Nosratola D, Roberts Christian K
Division of Nephrology and Hypertension, Department of Medicine, University of California, Irvine, CA 92697-4066, USA.
Biochim Biophys Acta. 2004 Nov 5;1690(3):231-7. doi: 10.1016/j.bbadis.2004.06.013.
Chronic renal failure (CRF) has been documented to cause oxidative stress and alter nitric oxide (NO) metabolism. However, the effect of CRF on proteins related to NO bioactivity has not been investigated. The present study was designed to test the hypothesis that CRF would induce changes in caveolin-1 (Cav-1), soluble guanylate cyclase (sGC) and Akt, three proteins important in regulating NO synthase (NOS) functionality. Male Sprague-Dawley rats were randomized to CRF via 5/6 nephrectomy or sham-operated control groups. After 6 weeks, body weight, blood pressure, creatinine clearance, plasma creatinine, urinary cyclic guanosine monophosphate (cGMP) and immunodetectable levels of Cav-1, sGC and Akt were determined in the renal, aorta, heart and liver tissues from both groups. CRF resulted in marked decreases in body weight and creatinine clearance, and elevation of blood pressure and plasma creatinine. An apparent upregulation of sGC protein abundance in renal tissue was noted, with no change in aorta, heart and liver. This was accompanied by a reduction in urinary cGMP levels, indicative of sGC dysfunction. Cav-1 protein abundance was increased in aortic, liver and renal tissues. In contrast, CRF depressed Akt abundance in aorta, heart and liver tissues. These data document that CRF is characterized by alteration in the abundance of proteins regulating NO function in hepatic, vascular, cardiac and renal tissues, and a decrease in cGMP, which contributes to hypertension and changes in NO bioactivity previously noted in this model.
慢性肾衰竭(CRF)已被证明会导致氧化应激并改变一氧化氮(NO)代谢。然而,CRF对与NO生物活性相关蛋白质的影响尚未得到研究。本研究旨在验证以下假设:CRF会诱导小窝蛋白-1(Cav-1)、可溶性鸟苷酸环化酶(sGC)和Akt这三种在调节一氧化氮合酶(NOS)功能中起重要作用的蛋白质发生变化。将雄性Sprague-Dawley大鼠通过5/6肾切除术随机分为CRF组或假手术对照组。6周后,测定两组大鼠肾、主动脉、心脏和肝脏组织中的体重、血压、肌酐清除率、血浆肌酐、尿环磷酸鸟苷(cGMP)以及Cav-1、sGC和Akt的免疫检测水平。CRF导致体重和肌酐清除率显著降低,血压和血浆肌酐升高。肾组织中sGC蛋白丰度明显上调,而主动脉、心脏和肝脏中无变化。这伴随着尿cGMP水平降低,表明sGC功能障碍。主动脉、肝脏和肾组织中Cav-1蛋白丰度增加。相反,CRF使主动脉、心脏和肝脏组织中Akt丰度降低。这些数据表明,CRF的特征是肝、血管、心脏和肾组织中调节NO功能的蛋白质丰度发生改变,以及cGMP降低,这导致了该模型中先前观察到的高血压和NO生物活性变化。